Sign In to Follow Application
View All Documents & Correspondence

A Degron For Regulating Protein Expression And Methods Thereof

Abstract: ABSTRACT A DEGRON FOR REGUALTING PROTEIN EXPRESSION AND METHODS THEREOF The present disclosure provides a degron comprising an amino acid sequence having at least 70 % sequence identity to an amino acid sequence as set forth in SEQ ID NO: 1 for regulating the expression of a protein. The present disclosure also provides a fusion protein comprising a polypeptide of interest and the degron. Further, the present disclosure relates to a method of producing the fusion protein and a method of regulating the expression of a polypeptide of interest.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
23 February 2024
Publication Number
10/2024
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2025-02-21
Renewal Date

Applicants

INDIAN INSTITUTE OF SCIENCE
INDIAN INSTITUTE OF SCIENCE, Sir C V Raman Road BENGALURU, KARNATAKA – 560012, India

Inventors

1. ESWARAPPA, Sandeep M
INDIAN INSTITUTE OF SCIENCE, Sir C V Raman Road BENGALURU, KARNATAKA - 560012, India
2. MANJUNATH, Lekha E
INDIAN INSTITUTE OF SCIENCE, Sir C V Raman Road BENGALURU, KARNATAKA – 560012, India

Specification

I/We Claim:
1. A degree comprising an amino acid sequence having at least 70 % sequence
identity to an amino acid sequence as set forth in SEQ ID NO: 1 for
regulating the expression of a protein.
5 2. The degree as claimed in claim 1, wherein the degree comprises an amino
acid sequence selected from the group consisting of SEQ ID NO: 2, SEQ
ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7,
and SEQ ID NO: 8.
3. The degron as claimed in claim 1 or claim 2, wherein the degree is encoded
10 by a nucleotide sequence, having a sequence selected from the group
consisting of SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID
NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID
NO: 16.
4. The degron as claimed in claim 1, wherein the degron is present at the C15 terminus of the protein.
5. A fusion protein, comprising:
a) a polypeptide of interest; and
b) the degron as claimed in claim 1;
wherein the degron is operable linked to the polypeptide of interest;
20 and the fusion protein has an amino acid sequence selected from a
group consisting of SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19,
and SEQ ID NO: 20.
6. The fusion protein as claimed in claim 5, wherein the fusion protein
further comprises a tag and/or a detectable label.
25 7. The fusion protein as claimed in claim 6, wherein the tag is selected from
FLAG, HA, myc, His, GST, V5, MBP, or Biotin; and the detectable label is
selected from fluorescent label (GFP, m Cherry, REP, DsRed, YFP, CFP),
or luminescent label (Firefly luciferase, Renilla luciferase, nanoLuc,
Gaussia luciferase).
20
8. The fusion protein as claimed in claim 5, wherein the polypeptide of
interest is selected from the group consisting of GFP, MTCH, Renilla
luciferase, and mtDsRed.
9. A polynucleotide encoding the fusion protein as claimed in claim 5.
5 10. The polynucleotide as claimed in claim 9, wherein the polynucleotide has
a nucleotide sequence selected from the group consisting of SEQ ID NO:
21, SEQ ID MO: 22, SEQ ID NO: 23, and SEQ ID NO: 24.
11. A nucleotide construct comprising the polynucleotide as claimed in claim
9, operably linked to a promoter; wherein the promoter is selected from a
10 group consisting of CMV promoter, EF1α promoter, chicken β-actin
promoter, SV40 promoter, Ubc promoter, and CAG promoter.
12. The nucleotide construct as claimed in claim 11, wherein the nucleotide
construct has a nucleotide sequence selected from SEQ ID NO: 25, SEQ
ID NO: 26, SEQ ID NO: 27, or SEQ ID NO : 28.
15 13. An expression vector comprising the nucleotide construct as claimed in
claim 11.
14. A host cell comprising the nucleotide construct as claimed in claim 11 or
the expression vector as claimed in claim 13.
15. The host cell as claimed in claim 14, wherein the host cell is a eukaryotic
20 cell; and the eukaryotic cell is selected from a group consisting of HEK293,
HeLa, K562, Neuro2a, U2OS, HepG2, A542, CACO2, CaOV3,
Saccharomyces cerevisiae, and Saccharomyces pombe.
16. A method of producing a fusion protein as claimed in claim 5, wherein the
method comprises:
25 a) transforming a host cell with the nucleotide construct as claimed in
claim 11 or the expression vector as claimed in claim 13 to obtain a
transformed host cell; and
b) culturing the transformed host cell under conditions favoring the
production of the fusion protein.
30 17. A method for regulating the expression of a polypeptide of interest,
wherein the method comprises:
21
a) transforming a host cell with the nucleotide construct as claimed in
claim 11 or the expression vector as claimed in claim 13;
b) culturing the transformed host cell under conditions favoring the
production of the fusion protein; and
5 c) detecting the presence or absence of a change in the expression of the
polypeptide of interest in the transformed host cell with reference to a
host cell not transformed with said nucleotide construct.

Documents

Application Documents

# Name Date
1 202441013294-STATEMENT OF UNDERTAKING (FORM 3) [23-02-2024(online)].pdf 2024-02-23
2 202441013294-Sequence Listing in XML (WIPO ST26) [23-02-2024(online)].pdf 2024-02-23
3 202441013294-Sequence Listing in PDF [23-02-2024(online)].pdf 2024-02-23
4 202441013294-REQUEST FOR EARLY PUBLICATION(FORM-9) [23-02-2024(online)].pdf 2024-02-23
5 202441013294-POWER OF AUTHORITY [23-02-2024(online)].pdf 2024-02-23
6 202441013294-FORM-9 [23-02-2024(online)].pdf 2024-02-23
7 202441013294-FORM FOR SMALL ENTITY(FORM-28) [23-02-2024(online)].pdf 2024-02-23
8 202441013294-FORM 1 [23-02-2024(online)].pdf 2024-02-23
9 202441013294-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [23-02-2024(online)].pdf 2024-02-23
10 202441013294-EDUCATIONAL INSTITUTION(S) [23-02-2024(online)].pdf 2024-02-23
11 202441013294-DRAWINGS [23-02-2024(online)].pdf 2024-02-23
12 202441013294-DECLARATION OF INVENTORSHIP (FORM 5) [23-02-2024(online)].pdf 2024-02-23
13 202441013294-COMPLETE SPECIFICATION [23-02-2024(online)].pdf 2024-02-23
14 202441013294-FORM-8 [27-02-2024(online)].pdf 2024-02-27
15 202441013294-FORM 18A [27-02-2024(online)].pdf 2024-02-27
16 202441013294-EVIDENCE OF ELIGIBILTY RULE 24C1f [27-02-2024(online)].pdf 2024-02-27
17 202441013294-Proof of Right [08-08-2024(online)].pdf 2024-08-08
18 202441013294-FER.pdf 2024-10-23
19 202441013294-FORM 3 [21-11-2024(online)].pdf 2024-11-21
20 202441013294-FER_SER_REPLY [05-12-2024(online)].pdf 2024-12-05
21 202441013294-US(14)-HearingNotice-(HearingDate-07-02-2025).pdf 2025-01-07
22 202441013294-FORM-26 [29-01-2025(online)].pdf 2025-01-29
23 202441013294-Correspondence to notify the Controller [29-01-2025(online)].pdf 2025-01-29
24 202441013294-Written submissions and relevant documents [19-02-2025(online)].pdf 2025-02-19
25 202441013294-PatentCertificate21-02-2025.pdf 2025-02-21
26 202441013294-IntimationOfGrant21-02-2025.pdf 2025-02-21
27 202441013294-Request Letter-Correspondence [06-03-2025(online)].pdf 2025-03-06
28 202441013294-Power of Attorney [06-03-2025(online)].pdf 2025-03-06
29 202441013294-Form 1 (Submitted on date of filing) [06-03-2025(online)].pdf 2025-03-06
30 202441013294-Covering Letter [06-03-2025(online)].pdf 2025-03-06
31 202441013294-CERTIFIED COPIES TRANSMISSION TO IB [06-03-2025(online)].pdf 2025-03-06

Search Strategy

1 degronseq1E_21-10-2024.pdf
2 202441013294E_21-10-2024.pdf

ERegister / Renewals

3rd: 26 Feb 2025

From 23/02/2026 - To 23/02/2027

4th: 26 Feb 2025

From 23/02/2027 - To 23/02/2028

5th: 26 Feb 2025

From 23/02/2028 - To 23/02/2029

6th: 26 Feb 2025

From 23/02/2029 - To 23/02/2030

7th: 26 Feb 2025

From 23/02/2030 - To 23/02/2031

8th: 26 Feb 2025

From 23/02/2031 - To 23/02/2032

9th: 26 Feb 2025

From 23/02/2032 - To 23/02/2033

10th: 26 Feb 2025

From 23/02/2033 - To 23/02/2034